These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12593122)

  • 1. Resource utilization in home health chronic obstructive pulmonary disease management.
    Steinel JA; Madigan EA
    Outcomes Manag; 2003; 7(1):23-7. PubMed ID: 12593122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of a disease management program for chronic obstructive pulmonary disease.
    Dewan NA; Rice KL; Caldwell M; Hilleman DE
    COPD; 2011 Jun; 8(3):153-9. PubMed ID: 21513435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
    Wilson L; Devine EB; So K
    Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization?
    Rasekaba TM; Williams E; Hsu-Hage B
    Chron Respir Dis; 2009; 6(3):157-63. PubMed ID: 19643830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
    Mittmann N; Kuramoto L; Seung SJ; Haddon JM; Bradley-Kennedy C; Fitzgerald JM
    Respir Med; 2008 Mar; 102(3):413-21. PubMed ID: 18086519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitutive "hospital at home" versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial.
    Aimonino Ricauda N; Tibaldi V; Leff B; Scarafiotti C; Marinello R; Zanocchi M; Molaschi M
    J Am Geriatr Soc; 2008 Mar; 56(3):493-500. PubMed ID: 18179503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of chronic obstructive pulmonary disease.
    Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD: illness severity, resource utilisation and cost.
    Tynan AJ; Lane SJ
    Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of COPD exacerbations in the emergency department and inpatient setting.
    Dalal AA; Shah M; D'Souza AO; Rane P
    Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
    Dal Negro RW; Tognella S; Tosatto R; Dionisi M; Turco P; Donner CF
    Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of home hospitalization on healthcare costs of exacerbations in COPD patients.
    Puig-Junoy J; Casas A; Font-Planells J; Escarrabill J; Hernández C; Alonso J; Farrero E; Vilagut G; Roca J
    Eur J Health Econ; 2007 Dec; 8(4):325-32. PubMed ID: 17221178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease.
    Rea H; McAuley S; Stewart A; Lamont C; Roseman P; Didsbury P
    Intern Med J; 2004 Nov; 34(11):608-14. PubMed ID: 15546454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of outreach respiratory care for COPD patients.
    Gordois A; Scuffham P; Gibbons D
    Prof Nurse; 2002 Apr; 17(8):504-7. PubMed ID: 11997968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mixed method study to compare use and experience of hospital care and a nurse-led acute respiratory assessment service offering home care to people with an acute exacerbation of chronic obstructive pulmonary disease.
    Schofield I; Knussen C; Tolson D
    Int J Nurs Stud; 2006 May; 43(4):465-76. PubMed ID: 16157339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.